About Ionpath
Ionpath is a company based in Menlo Park (United States) founded in 2014. Ionpath has raised $18 million across 3 funding rounds from investors including Thermo Fisher Scientific, Bruker and Samsara BioCapital. The company has 37 employees as of December 31, 2020. Ionpath operates in a competitive market with competitors including Oxford Instruments, Leica Microsystems, Scholar Rock, SpectraWAVE and IBA, among others.
- Headquarter Menlo Park, United States
- Employees 37 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ionpath, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$18 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Thermo Fisher Scientific
& 7 more
-
Employee Count
37
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Ionpath
Unlock access to complete
Unlock access to complete
Funding Insights of Ionpath
Ionpath has successfully raised a total of $18M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ionpath
Ionpath has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Thermo Fisher Scientific, Bruker and Samsara BioCapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funding is provided by Samsara BioCapital in California.
|
Locked | Locked | Locked | |
|
Early-stage VC firm focused on life science startups
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Ionpath
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ionpath
Investment portfolio details for Ionpath
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ionpath
Detailed financials for Ionpath
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ionpath Comparisons
Peer comparison for Ionpath
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ionpath
Ionpath operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Instruments, Leica Microsystems, Scholar Rock, SpectraWAVE and IBA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Technology tools and systems for molecular scale are developed.
|
|
| Locked | Locked | Locked |
Imaging solutions for macro, micro, and nano structures are provided.
|
|
| Locked | Locked | Locked |
Antibody-based drugs for primary myopathies are developed and targeted.
|
|
| Locked | Locked | Locked |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| Locked | Locked | Locked |
Innovative solutions for cancer treatment and industrial applications are provided by IBA.
|
|
| Locked | Locked | Locked |
A surgical digital microscope for tumor resection is developed.
|
Detailed competitors of Ionpath
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ionpath
Complete news archive for Ionpath
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ionpath
Ionpath was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Ionpath is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Paul Davy is the current CEO of Ionpath.
Ionpath is a funded company, having raised a total of $18M across 3 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Ionpath is 37.
Developer of an imaging platform for tissue biopsies. It has designed a mass spec-based imaging platform for tissue biopsy called multiplexed ion beam imaging. The platform allows higher resolution and more samples can be screened simultaneously than the optical microscope and other mass spec-based imaging systems. The technology has diverse applications and can be used in research as well as diagnostic sectors.
Ionpath's top competitors include Oxford Instruments, Scholar Rock and Leica Microsystems.
Ionpath has 8 investors. Key investors include Thermo Fisher Scientific, Bruker, Samsara BioCapital, Genoa Ventures, and Norwich Ventures.